Abeona Therapeutics Inc (NASDAQ:ABEO) traded at $3.26 at close of the session on Friday, April 26, made an upward move of 2.19% on its previous day’s price.
Looking at the stock we see that its previous close was $3.19 . In terms of its 52-week price range, ABEO has a high of $9.01 and a low of $2.83. The company’s stock has lost about -55.59% over that past 30 days.
Abeona Therapeutics Inc has a market cap of $89.19 million. Estimates by analysts give the company expected earnings per share (EPS) of -$0.51, with the EPS growth for the year raised at -$2.14 for 2024 and -$1.9 for next year. These figures represent 15.40% and 11.20% growth in EPS for the two years respectively.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $170k, with a high of $500k. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2024 is expected to hit $500k, or -85.70% down from figures reported last year.
There have been 2 upward and — downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the ABEO stock, short term indicators assign the stock an average of Hold, while medium term indicators assign it an average of 50% Buy. Long term indicators on average place the stock in the category of 50% Sell.
Looking further, we note the current price level is -53.05% off its SMA20 and -55.18% from its 50-day simple moving average. The RSI (14) is pointing at 20.97 while the volatility over the past week is 11.80% and jumps to 7.91% over the past one month. The beta value is 1.62, while the average true range (ATR) is currently pointing at 0.68.
Coming back to Abeona Therapeutics Inc (NASDAQ:ABEO), we note that the average 3-month trading volume was 502.41K. Current shares outstanding are 26.52 million.
The insiders hold 5.27% of the company’s shares while institutions hold 52.12%. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -34.93% down in year-to-date price movement.
